Tokyo, Japan

Miyuki Uchida



Average Co-Inventor Count = 4.3

ph-index = 1

Forward Citations = 55(Granted Patents)


Location History:

  • Tokyo, JP (2006 - 2008)
  • Minato-ku, JP (2011)

Company Filing History:


Years Active: 2006-2011

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Miyuki Uchida

Introduction

Miyuki Uchida is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds and methods. With a total of three patents to her name, Uchida's work has the potential to impact drug formulation and synthesis.

Latest Patents

Uchida's latest patents include an acid addition salt of irinotecan. This invention focuses on creating an irinotecan acid addition salt through the addition of various acids, such as sulfuric acid and citric acid. The resulting salt does not require heating during drug preparation, allowing for a stable aqueous drug product. Another notable patent is a method for synthesizing camptothecin-related compounds. This invention aims to efficiently prepare specific compounds that are essential for the total synthesis of camptothecin, a starting material for irinotecan hydrochloride and its derivatives.

Career Highlights

Miyuki Uchida is associated with Kabushiki Kaisha Yakult Honsha, a company known for its commitment to health and wellness through innovative products. Her work at Yakult Honsha has allowed her to focus on pharmaceutical advancements that can lead to improved therapeutic options.

Collaborations

Uchida collaborates with esteemed colleagues, including Seigo Sawada and Takanori Ogawa. Their combined expertise fosters a productive environment for innovation and research.

Conclusion

Miyuki Uchida's contributions to the pharmaceutical industry through her patents and collaborative efforts highlight her role as a leading inventor. Her work continues to pave the way for advancements in drug formulation and synthesis.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…